CEL-SCI Corp (CVM) Earnings growth forecast for next year
CEL-SCI Corporation (CVM) complements its own Maryland facility with the implementation of automated bioreactors to eliminate synthesis errors. The projected earnings per share growth benchmark in the daily price action on the GURU.Markets chart confirms this trajectory, where 0.00 shows the current volume of the metric. The prospects for CEL-SCI Corporation (CVM) rely on the development of Multikine and the expected FDA approval for head and neck cancer therapy.
CVM (CEL-SCI Corp.): analytical breakdowns and indicator data
- share price and consensus valuation forecast:
- market capitalization details:
- book capitalization indicators:
- issuer credit burden and liquidity indicators:
- net income and valuation ratios data:
CVM - Net Income|Expected Profit CEL-SCI Corporation|CVM - Market Cap to Earnings|Future Price to Earnings cel-sci.com|CVM - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CEL-SCI Corporation|CVM - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months CEL-SCI|CVM - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months cel-sci.com|CVM - Earnings per share increase in current year|Earnings growth forecast for next year CEL-SCI Corporation
- company sales and revenue statistics:
Comprehensive company analysis:CEL-SCI Corp, CVM
CEL-SCI Corporation (CVM) maintains its own facility in Maryland with redundant ventilation systems to ensure biosynthesis stability, which directly impacts the projected trajectory of net income. This indicator aggregates expert expectations for next year's profit changes, measuring EPS growth rates relative to current values. Analyzing this metric allows for an assessment of capitalization potential, although overly optimistic expectations may mask risks of declining asset liquidity.
Competitor analysis
ONC (BeiGene Ltd) - Earnings growth forecast for next year|Expected net earnings per share growth next year Halozyme Therapeutics HALO|Net earnings per share growth forecast for next year Revolution Medicines, Inc. (RVMD)|Earnings growth forecast for next year Ascentage Pharma Group International (AAPG)|Earnings growth forecast for next year CGON (CG Oncology Inc)|Expected earnings per share trend next year URGN|bicara.com - Earnings growth forecast for next year|Expected earnings per share trend next year PSNL (personalis.com)|Erasca Inc (ERAS) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Delcath Systems|YMAB (YmAbs) - Earnings growth forecast for next year|AURA: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Candel Therapeutics, Inc. (CADL)|Earnings growth forecast for next year Accuray (ARAY)|Net earnings per share growth forecast for next year SELLAS Life Sciences Group Inc. SLS|Actuate Therapeutics, Inc (ACTU) - Expected net earnings per share growth next year|CTOR - Net earnings per share growth forecast for next year|HURA: Net earnings per share growth forecast for next year|TARA (Protara) - Expected earnings per share growth for next year|Fate Therapeutics, Inc. - Expected earnings per share trend next year|WHWK (aadibio.com) - Earnings growth forecast for next year|TCRX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Champions Oncology (CSBR)|XBiotech - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year ostherapies.com OSTX|Projected earnings per share increase next year RADX (Radiopharm Theranostics Limited)|Artiva - Earnings growth forecast for next year|ANL: Net earnings per share growth forecast for next year|VERU: Earnings growth forecast for next year|Net earnings per share change forecast for next year TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Earnings growth forecast for next year|Expected net earnings per share growth next year renovarobio.com RENB|Net earnings per share growth forecast for next year muraloncology.com (MURA)|Projected earnings per share increase next year KAPA|Earnings growth forecast for next year OKUR (onkuretherapeutics.com)|Projected earnings per share increase next year GDTC (CytoMed)|Curis - Earnings growth forecast for next year|APLM: Net earnings per share growth forecast for next year|Tharimmune (THAR) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Advanced Biomed Inc.|GNPX (Genprex Inc) - Earnings growth forecast for next year|Calidi Biotherapeutics (CLDI) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year SBFM|Net earnings per share growth forecast for next year XBIO (Xenetic Biosciences, Inc.)|Earnings growth forecast for next year SLRX (salariuspharma.com)|PPBT - Expected earnings per share growth for next year|AONC - Net earnings per share growth forecast for next year|Expected earnings per share trend next year BGNE (BeOne Medicines)|CKPT: Earnings growth forecast for next year|Elevation Oncology Inc. (ELEV) - Earnings growth forecast for next year|ICAD (iCAD) - Earnings growth forecast for next year|Earnings growth forecast for next year ikenaoncology.com|Earnings growth forecast for next year NTBL|Earnings growth forecast for next year Viracta Therapeutics Inc. (VIRX)|Net earnings per share growth forecast for next year MorphoSys Inc MOR|Expected earnings per share trend next year NAYA|AAPGV: Expected earnings per share growth for next year
